Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT05273359 · UNKNOWN

Trial details

NCT number: NCT05273359
Sponsor: Temple University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2023-04-01
Primary completion: 2024-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.